Freedman A R, Kerr J C, Swan K G, Hobson R W
Gastroenterology. 1978 May;74(5 Pt 1):875-8.
The effects of vasopressin on blood flow in the superior mesenteric artery and on mean arterial pressure and portal venous pressure were measured in 7 rhesus monkeys. Vasopressin was injected, as either a bolus, or infused both intravenously and intraarterially to assess the influence of the route of administration upon hemodynamic responses. Dose-dependent decreases in superior mesenteric arterial flow were observed during both intraarterial and intravenous injections of vasopressin. No statistically significant differences between the two routes of administration, the decrease in flow, and changes in pressure were observed. Based upon these observations, one might anticipate that intravenously administered vasopressin will be as effective as intraarterially administered vasopressin in reducing mesenteric blood flow, and thus portal venous pressure, in man.
在7只恒河猴身上测量了血管加压素对肠系膜上动脉血流、平均动脉压和门静脉压的影响。血管加压素以推注形式注射,或通过静脉内和动脉内输注,以评估给药途径对血流动力学反应的影响。在动脉内和静脉内注射血管加压素期间,均观察到肠系膜上动脉血流呈剂量依赖性下降。两种给药途径在血流减少和压力变化方面未观察到统计学上的显著差异。基于这些观察结果,人们可能预期静脉注射血管加压素在降低人体肠系膜血流以及门静脉压方面与动脉内注射血管加压素同样有效。